Product Name:5-methyl-2-piperazin-1-yl-1,3-thiazole;dihydrochloride
IUPAC Name:1-(5-methyl-1,3-thiazol-2-yl)piperazine hydrochloride
Packing Unit | Available Stock | Price($) | Quantity |
---|
Product Overview |
1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride (1-MTPD) is a novel synthetic compound belonging to the class of heterocyclic compounds. It is an analogue of the piperazine class of compounds. |
Synthesis Method |
1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride can be synthesized using a variety of methods, including the condensation of 1-methyl-1,3-thiazol-2-yl piperazine and hydrochloric acid. The reaction is carried out in an aqueous medium at a temperature of 60-70 °C. The reaction is typically complete in 1-2 hours and yields a white crystalline solid. |
Chemical Properties |
1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride is also relatively non-toxic and has been found to have a wide range of pharmacological effects. It is a relatively stable compound that can be easily synthesized and purified. It is sensitive to light and heat, and it can easily be degraded in the presence of oxygen. 1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride is also a relatively expensive compound. |
Synthesis and Application |
1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride has been studied extensively for its pharmacological effects in both in vitro and in vivo studies. In vitro studies have demonstrated that 1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride has anticonvulsant, anxiolytic, anti-inflammatory, anti-tumor, and anti-allergic activities. In addition, 1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride has also been shown to have potential applications in the treatment of various neurological disorders, such as epilepsy, Parkinson’s disease, and Alzheimer’s disease. |
Future Directions |
Future research should focus on exploring the potential therapeutic applications of 1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride in the treatment of various neurological disorders, such as epilepsy, Parkinson’s disease, and Alzheimer’s disease. In addition, further research should also focus on exploring the potential of 1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride as an anti-tumor agent and as an anti-allergic agent. Finally, future studies should also focus on exploring the potential of 1-(5-Methyl-1,3-thiazol-2-yl)piperazine dihydrochloride as an anti-inflammatory agent. |